Literature DB >> 36213370

Exceptional Extension of Benign Angiomyolipoma in the Renal Vein.

Darius Lepot1, Patrick Mailleux2, Stéphane B Van den Broeck2.   

Abstract

Teaching Point: When a renal angiomyolipoma (AML) is incidentally detected on imaging, the venous system should be assessed for intravascular fat component. Copyright:
© 2022 The Author(s).

Entities:  

Keywords:  abdominal imaging; angiomyolipoma; renal neoplasm; renal vein extension; unenhanced CT

Year:  2022        PMID: 36213370      PMCID: PMC9504089          DOI: 10.5334/jbsr.2854

Source DB:  PubMed          Journal:  J Belg Soc Radiol        ISSN: 2514-8281            Impact factor:   1.912


Case History

A 61-year-old female was admitted to the emergency department for epigastric pain following epigastric hernia surgery. An abdominal unenhanced computed tomography (CT) demonstrated a reoccurrence of epigastric eventration. As an incidental finding, two round well-defined lesions of fat density (–78 HU) containing tortuous foci of enhancing vessels features strongly suggestive of renal AMLs (asterisk in Figure 1). Both AMLs showed a fourfold increase in size to prior imaging 10 years ago; the right posterior cortical AML measured 6.6 cm and left anterior hilar AML measured 3.2 cm (arrowheads in Figure 2).
Figure 1
Figure 2
The lipomatous component unexpectedly extended into the left renal vein, forming one 4.5 cm fat density intravascular flap (arrows on Figures 1 and 3A) and a second, smaller, 2 cm intravascular fat density lesion located more proximally, in a tributary vein (arrowheads in Figures 1 and 3). A contrast-enhanced CT outlined the intravenous extension more clearly, showed no extension into the inferior vena cava, and excluded pulmonary embolism (PE).
Figure 3
Total left nephrectomy and right partial nephrectomy were planned. Histologic examination confirmed the diagnosis of AML without any evidence of sarcomatoid dedifferentiation.

Comment

AML is a common asymptomatic benign renal neoplasm mostly detected incidentally during abdominal cross-sectional imaging. It is composed of thick-walled blood vessels, smooth muscle, and mature adipose tissue. In 20% of cases there will be an association with tuberous sclerosis manifesting as multifocal and bilateral AMLs. A common symptomatic presentation occurring with large AMLs (>4 cm) and leading to surgical treatment or embolization is spontaneous retroperitoneal hemorrhage sometimes complicated by hypotensive shock. A rare case of AML showing liposarcomatous transformation has also been reported. Aggressive patterns with intravascular growth is a rare condition only described in a couple of case reports [1]. Mostly the extension occurs in the renal veins and inferior vena cava (IVC). Extension of a lipomatous thrombus in a renal vein tributary, as in our case, has not yet been described. The increased risk for PE emphasizes the need for surgery and sometimes for IVC filter placement [2]. Even a benign, and relatively frequently encountered, AML can rarely exhibit aggressive behavior, with intravascular potentially life-threatening fat extension. The radiologist should pay attention to this and attentively review the renal veins and IVC for a fat density component that suggests intravascular extension or embolization [3]. Therapeutic options, that is, potentially lifesaving surgery must be discussed with the patient.
  3 in total

1.  Aggressive renal angiomyolipoma with vena cava extension: A case report and literature review.

Authors:  Gang Shen; Qiqi Mao; Hanjin Yang; Chaojun Wang
Journal:  Oncol Lett       Date:  2014-08-08       Impact factor: 2.967

2.  Preoperative inferior vena cava filter implantation to prevent pulmonary fat embolism in a patient showing renal angiomyolipoma extension into the renal vein: A case report and literature review.

Authors:  Motohiro Fujiwara; Naoko Kawamura; Tetsuo Okuno
Journal:  J Rural Med       Date:  2018-11-29

3.  Renal Angiomyolipoma With Caval Extension and Pulmonary Fat Embolism: A Case Report.

Authors:  Suleyman Utku Celik; Akin Firat Kocaay; Yusuf Sevim; Omer Arda Cetinkaya; Ebru Dusunceli Atman; Iskender Alacayir
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.